Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer(389 views) Cella L, D'Avino V, Liuzzi R, Conson M, Doria F, Faiella A, Loffredo F, Salvatore M, Pacelli R
Keywords: Anticoagulant Agent, Antihypertensive Agent, Acute Toxicity, Adult, Article, Cancer Hormone Therapy, Cancer Radiotherapy, Cancer Size, External Beam Radiotherapy, Follow Up, Gastrointestinal Toxicity, Gleason Score, Human, Major Clinical Study, Probability, Prostate Cancer, Radiation Dose, Risk Assessment, Scoring System, Area Under The Curve, Computer Assisted Radiotherapy, Gastrointestinal Tract, Middle Aged, Multivariate Analysis, Procedures, Prostatic Neoplasms, Radiation Injuries, Radiation Response, Radiometry, Receiver Operating Characteristic, Very Elderly, 80 And Over, Area Under Curve, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Roc Curve,
Affiliations: *** IBB - CNR ***
Institute of Biostructures and Bioimaging, National Council of Research (CNR), Naples, Italy
Department of Advanced Biomedical Sciences, Federico II University School of Medicine, Naples, Italy
Department of Physics, University Federico II, Naples, Italy
References: Michalski, J.M., Gay, H., Jackson, A., Radiation dose-volume effects in radiation-induced rectal injury (2010) Int J Radiat Oncol Biol Phys, 76 (3 SUPPL.), pp. S123-S129. , 3319467, 2017150
Cella, L., Lomax, A., Miralbell, R., New techniques in hadrontherapy: intensity modulated proton beams (2001) Phys Med, 17 (SUPPL. 1), pp. 100-102
Skala, M., Rosewall, T., Dawson, L., Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer (2007) Int J Radiat Oncol Biol Phys, 68 (3), pp. 690-698. , 10.1016/j.ijrobp.2006.12.064, 17379434
Efstathiou, J.A., Gray, P.J., Zietman, A.L., Proton beam therapy and localised prostate cancer: current status and controversies (2013) Br J Cancer, 108 (6), pp. 1225-1230. , 10.1038/bjc.2013.100, 23481182
Gulliford, S.L., Partridge, M., Sydes, M.R., Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise (2012) Radiother Oncol, 102 (3), pp. 347-351. , 10.1016/j.radonc.2011.10.022, 22119373
Defraene, G., Van den Bergh, L., Al-Mamgani, A., The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer (2012) Int J Radiat Oncol Biol Phys, 82 (3), pp. 1233-1242. , 10.1016/j.ijrobp.2011.03.056, 21664059
Fellin, G., Fiorino, C., Rancati, T., Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study (2009) Radiother Oncol, 93 (2), pp. 197-202. , 10.1016/j.radonc.2009.09.004, 19828205
Valdagni, R., Kattan, M.W., Rancati, T., Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome (2012) Int J Radiat Oncol Biol Phys, 82 (5), pp. 1957-1966. , 10.1016/j.ijrobp.2011.03.028, 21640511
Valdagni, R., Vavassori, V., Rancati, T., Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial (2012) Radiother Oncol, 103 (2), pp. 252-255. , 10.1016/j.radonc.2012.03.012, 22521747
Cella, L., Conson, M., Caterino, M., Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma (2012) Int J Radiat Oncol Biol Phys, 82 (5), pp. 1802-1808. , 10.1016/j.ijrobp.2010.09.054, 21514076
Cella, L., Liuzzi, R., Conson, M., Multivariate normal tissue complication probability modeling of heart valve dysfunction in hodgkin lymphoma survivors (2013) Int J Radiat Oncol Biol Phys, 87 (2), pp. 304-310. , 10.1016/j.ijrobp.2013.05.049, 23886419
El Naqa, I., Bradley, J., Blanco, A.I., Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors (2006) Int J Radiat Oncol Biol Phys, 64 (4), pp. 1275-1286. , 10.1016/j.ijrobp.2005.11.022, 16504765
El Naqa, I., Suneja, G., Lindsay, P.E., Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships (2006) Phys Med Biol, 51 (22), pp. 5719-5735. , 10.1088/0031-9155/51/22/001, 17068361
Gay, H.A., Barthold, H.J., O'Meara, E., Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas (2012) Int J Radiat Oncol Biol Phys, 83 (3), pp. e353-e362. , 10.1016/j.ijrobp.2012.01.023, 22483697
Cox, J.D., Stetz, J., Pajak, T.F., Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) (1995) Int J Radiat Oncol Biol Phys, 31 (5), pp. 1341-1346. , 10.1016/0360-3016(95)00060-C, 7713792
Pacelli, R., Conson, M., Cella, L., Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximatedgenetic subtypes (2013) J Radiat Res, 54 (2), pp. 292-298. , 10.1093/jrr/rrs087, 3589925, 23019151
Pedicini, P., Caivano, R., Strigari, L., In regard to Miralbell et al. Re: Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: alpha/beta = 1.4 (0.9-2.2) Gy (2013) Int J Radiat Oncol Biol Phys, 85 (1), pp. 10-11. , 10.1016/j.ijrobp.2012.03.056, 23237001
Pedicini, P., Strigari, L., Benassi, M., Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer (2013) Int J Radiat Oncol Biol Phys, 85 (5), pp. e231-7. , 10.1016/j.ijrobp.2012.11.033, 23332226
Hamstra, D.A., Stenmark, M.H., Ritter, T., Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer (2013) Int J Radiat Oncol Biol Phys, 85 (5), pp. 1246-1253. , 10.1016/j.ijrobp.2012.10.042, 23265567
Trott, K.R., Doerr, W., Facoetti, A., Biological mechanisms of normal tissue damage: importance for the design of NTCP models (2012) Radiother Oncol, 105 (1), pp. 79-85. , 10.1016/j.radonc.2012.05.008, 22748390
van der Schaaf, A., Xu, C.J., van Luijk, P., Multivariate modeling of complications with data driven variable selection: guarding against overfitting and effects of data set size (2012) Radiother Oncol, 105 (1), pp. 115-121. , 10.1016/j.radonc.2011.12.006, 22264894
Heemsbergen, W.D., Peeters, S.T., Koper, P.C., Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage (2006) Int J Radiat Oncol Biol Phys, 66 (1), pp. 3-10. , 10.1016/j.ijrobp.2006.03.055, 16814954
Kharofa, J., Cohen, E.P., Tomic, R., Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy (2012) Int J Radiat Oncol Biol Phys, 84 (1), pp. 238-243. , 10.1016/j.ijrobp.2011.11.013, 22300564
Lee, T.C., Greene-Schloesser, D., Payne, V., Chronic administration of the angiotensin-converting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment (2012) Radiat Res, 178 (1), pp. 46-56. , 10.1667/RR2731.1, 3422865, 22687052
Rehman, A., Schiffrin, E.L., Vascular effects of antihypertensive drug therapy (2010) Curr Hypertens Rep, 12 (4), pp. 226-232. , 10.1007/s11906-010-0117-3, 20514556
Dorr, W., Hendry, J.H., Consequential late effects in normal tissues (2001) Radiother Oncol, 61 (3), pp. 223-231. , 10.1016/S0167-8140(01)00429-7, 11730991
Buettner, F., Gulliford, S.L., Webb, S., Using Bayesian logistic regression to evaluate a new type of dosimetric constraint for prostate radiotherapy treatment planning (2010) Med Phys, 37 (4), pp. 1768-1777. , 10.1118/1.3367013, 20443499
Valdagni, R., Rancati, T., Reducing rectal injury during external beam radiotherapy for prostate cancer (2013) Nat Rev Urol, 10 (6), pp. 345-357. , 10.1038/nrurol.2013.96, 23670182
Loeffler, J.S., Durante, M., Charged particle therapy-optimization, challenges and future directions (2013) Nat Rev Clin Oncol, 10 (7), pp. 411-424. , 10.1038/nrclinonc.2013.79, 23689752
Michalski, J. M., Gay, H., Jackson, A., Radiation dose-volume effects in radiation-induced rectal injury (2010) Int J Radiat Oncol Biol Phys, 76 (3 SUPPL.), pp. S123-S129. , 3319467, 2017150
Efstathiou, J. A., Gray, P. J., Zietman, A. L., Proton beam therapy and localised prostate cancer: current status and controversies (2013) Br J Cancer, 108 (6), pp. 1225-1230. , 10. 1038/bjc. 2013. 100, 23481182
Gulliford, S. L., Partridge, M., Sydes, M. R., Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise (2012) Radiother Oncol, 102 (3), pp. 347-351. , 10. 1016/j. radonc. 2011. 10. 022, 22119373
Gay, H. A., Barthold, H. J., O'Meara, E., Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas (2012) Int J Radiat Oncol Biol Phys, 83 (3), pp. e353-e362. , 10. 1016/j. ijrobp. 2012. 01. 023, 22483697
Cox, J. D., Stetz, J., Pajak, T. F., Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) (1995) Int J Radiat Oncol Biol Phys, 31 (5), pp. 1341-1346. , 10. 1016/0360-3016 (95) 00060-C, 7713792
Hamstra, D. A., Stenmark, M. H., Ritter, T., Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer (2013) Int J Radiat Oncol Biol Phys, 85 (5), pp. 1246-1253. , 10. 1016/j. ijrobp. 2012. 10. 042, 23265567
Trott, K. R., Doerr, W., Facoetti, A., Biological mechanisms of normal tissue damage: importance for the design of NTCP models (2012) Radiother Oncol, 105 (1), pp. 79-85. , 10. 1016/j. radonc. 2012. 05. 008, 22748390
Heemsbergen, W. D., Peeters, S. T., Koper, P. C., Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage (2006) Int J Radiat Oncol Biol Phys, 66 (1), pp. 3-10. , 10. 1016/j. ijrobp. 2006. 03. 055, 16814954
Lee, T. C., Greene-Schloesser, D., Payne, V., Chronic administration of the angiotensin-converting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment (2012) Radiat Res, 178 (1), pp. 46-56. , 10. 1667/RR2731. 1, 3422865, 22687052
Loeffler, J. S., Durante, M., Charged particle therapy-optimization, challenges and future directions (2013) Nat Rev Clin Oncol, 10 (7), pp. 411-424. , 10. 1038/nrclinonc. 2013. 79, 23689752
Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
No results.
Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer